13F Filings History of READYSTATE ASSET MANAGEMENT LP

Latest 13F report
Q4 2025 - 17 Feb 2026
Value $
$2,260,599,941
Signature - Title
Shellane Mulcahy - General Counsel & Chief Compliance Officer
Location
Chicago, IL
Summary
This page shows a list of all the recent 13F filings made by READYSTATE ASSET MANAGEMENT LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. READYSTATE ASSET MANAGEMENT LP reported 373 stock holdings with total value $2,260,599,941 as of Q4 2025. Top holdings included IVV, RIVIAN AUTOMOTIVE INC, GRANITE CONSTR INC, MIRUM PHARMACEUTICALS INC, and HSY.

Notify me when READYSTATE ASSET MANAGEMENT LP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 373 $2,260,599,941 +$1,019,543,852 -$907,969,536 +$111,574,316 IVV, RIVIAN AUTOMOTIVE INC, GRANITE CONSTR INC, MIRUM PHARMACEUTICALS INC, HSY 13F-HR 17 Feb 2026, 16:00
Q3 2025 348 $2,053,295,595 +$713,602,134 -$1,120,065,974 -$406,463,840 RIVIAN AUTOMOTIVE INC, GRANITE CONSTR INC, MIRUM PHARMACEUTICALS INC, LQD, CYBR 13F-HR 07 Nov 2025, 13:19
Q2 2025 581 $2,408,157,790 +$1,226,441,451 -$881,637,971 +$344,803,480 RIVIAN AUTOMOTIVE INC, GRANITE CONSTR INC, HYG, HSY, MIRUM PHARMACEUTICALS INC 13F-HR 07 Aug 2025, 14:44
Q1 2025 377 $1,992,481,049 +$820,444,565 -$1,168,512,011 -$348,067,446 RIVIAN AUTOMOTIVE INC, GRANITE CONSTR INC, HYG, ITCI, K 13F-HR 06 May 2025, 10:44
Q4 2024 395 $2,376,828,111 +$1,079,825,823 -$614,653,161 +$465,172,662 IVV, GRANITE CONSTR INC, RIVIAN AUTOMOTIVE INC, HES, MIRUM PHARMACEUTICALS INC 13F-HR 14 Feb 2025, 16:00
Q3 2024 273 $1,919,881,077 +$712,442,743 -$974,081,914 -$261,639,171 GRANITE CONSTR INC, TRANSMEDICS GROUP INC, HES, FRESHPET INC, MIRUM PHARMACEUTICALS INC 13F-HR 14 Nov 2024, 16:00
Q2 2024 314 $2,104,920,043 +$712,937,529 -$1,424,029,853 -$711,092,324 SPY, TRANSMEDICS GROUP INC, GRANITE CONSTR INC, FRESHPET INC, MIRUM PHARMACEUTICALS INC 13F-HR 14 Aug 2024, 16:00
Q1 2024 219 $2,803,625,903 +$1,729,050,220 -$627,638,326 +$1,101,411,894 SPY, FRESHPET INC, WOLFSPEED INC, ASCENDIS PHARMA A/S, HES 13F-HR 10 May 2024, 18:25
Q4 2023 233 $1,676,236,079 +$825,712,589 -$418,774,048 +$406,938,541 QQQ, ALNYLAM PHARMACEUTICALS INC, WOLFSPEED INC, LANTHEUS HLDGS INC, SAREPTA THERAPEUTICS INC Restatement 01 Mar 2024, 15:03
Q3 2023 200 $1,198,946,110 +$566,657,185 -$349,910,017 +$216,747,168 PEABODY ENGR CORP, ARRAY TECHNOLOGIES INC, VERADIGM INC, ALNYLAM PHARMACEUTICALS INC, SAREPTA THERAPEUTICS INC 13F-HR 14 Nov 2023, 17:34
Q2 2023 161 $979,424,993 +$429,239,629 -$226,589,514 +$202,650,115 PEABODY ENGR CORP, ARRAY TECHNOLOGIES INC, QQQ, IMPINJ INC, VERADIGM INC 13F-HR 14 Aug 2023, 16:01
Q1 2023 115 $808,033,917 +$520,840,044 -$80,737,453 +$440,102,591 PEABODY ENGR CORP, SAREPTA THERAPEUTICS INC, AIRBNB INC, ARRAY TECHNOLOGIES INC, VCIT 13F-HR 15 May 2023, 16:01
Q4 2022 71 $357,891,671 $0 $0 $0 VCIT, ETSY INC, NATERA INC, ARRAY TECHNOLOGIES INC, AIRBNB INC 13F-HR 14 Feb 2023, 16:04